Evolus Net Worth
Evolus Net Worth Breakdown | EOLS |
Evolus Net Worth Analysis
Evolus' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Evolus' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Evolus' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Evolus' net worth analysis. One common approach is to calculate Evolus' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Evolus' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Evolus' net worth. This approach calculates the present value of Evolus' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Evolus' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Evolus' net worth. This involves comparing Evolus' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Evolus' net worth relative to its peers.
Enterprise Value |
|
To determine if Evolus is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Evolus' net worth research are outlined below:
| Evolus Inc generated a negative expected return over the last 90 days | |
| Evolus Inc has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 202.09 M. Net Loss for the year was (61.69 M) with profit before overhead, payroll, taxes, and interest of 92.73 M. | |
| Evolus Inc currently holds about 84.48 M in cash with (34.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.51. | |
| Over 80.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Heres Why Evolus Could be Great Choice for a Bottom Fisher |
Evolus Quarterly Good Will |
|
Evolus uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Evolus Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Evolus' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 13th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Evolus' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Evolus is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Evolus Inc backward and forwards among themselves. Evolus' institutional investor refers to the entity that pools money to purchase Evolus' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-06-30 | 1.2 M | Soleus Capital Management, L.p. | 2024-06-30 | 1.2 M | Boothbay Fund Management, Llc | 2024-06-30 | 996.5 K | Schroder Investment Management Group | 2024-06-30 | 977.6 K | Assenagon Asset Management Sa | 2024-09-30 | 955.6 K | Rice Hall James & Associates, Llc | 2024-09-30 | 904.9 K | Millennium Management Llc | 2024-06-30 | 899.4 K | D. E. Shaw & Co Lp | 2024-06-30 | 871.1 K | Soros Fund Management Llc | 2024-06-30 | 850 K | Nantahala Capital Management, Llc | 2024-06-30 | 5.8 M | Perceptive Advisors Llc | 2024-09-30 | 5.4 M |
Follow Evolus' market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 799.75 M.Market Cap |
|
Project Evolus' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.51) | (0.54) | |
| Return On Capital Employed | (0.35) | (0.37) | |
| Return On Assets | (0.33) | (0.34) | |
| Return On Equity | 2.98 | 3.13 |
When accessing Evolus' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Evolus' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Evolus' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Evolus' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Evolus Inc. Check Evolus' Beneish M Score to see the likelihood of Evolus' management manipulating its earnings.
Evaluate Evolus' management efficiency
Evolus Inc has return on total asset (ROA) of (0.0993) % which means that it has lost $0.0993 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (8.6168) %, meaning that it created substantial loss on money invested by shareholders. Evolus' management efficiency ratios could be used to measure how well Evolus manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to gain to 3.13 in 2024, whereas Return On Tangible Assets are likely to drop (0.54) in 2024. At this time, Evolus' Total Assets are comparatively stable compared to the past year. Intangibles To Total Assets is likely to gain to 0.57 in 2024, whereas Non Current Assets Total are likely to drop slightly above 63.4 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.36) | (0.35) | |
| Tangible Book Value Per Share | (1.56) | (1.64) | |
| Enterprise Value Over EBITDA | (15.86) | (16.65) | |
| Price Book Value Ratio | (28.97) | (27.52) | |
| Enterprise Value Multiple | (15.86) | (16.65) | |
| Price Fair Value | (28.97) | (27.52) | |
| Enterprise Value | 663.1 M | 696.2 M |
The decision-making processes within Evolus are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Enterprise Value Revenue 3.4011 | Revenue 248.3 M | Quarterly Revenue Growth 0.221 | Revenue Per Share 4.106 | Return On Equity (8.62) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Evolus insiders, such as employees or executives, is commonly permitted as long as it does not rely on Evolus' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Evolus insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Evolus Corporate Filings
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 6th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 6th of September 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 3rd of July 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Evolus Earnings per Share Projection vs Actual
Evolus Corporate Management
| Jessica Novak | Senior Resources | Profile | |
| Tomoko YamagishiDressler | Chief Officer | Profile | |
| CCFP DipSportMed | Chief RD | Profile | |
| David Erickson | VP Relations | Profile |
Additional Tools for Evolus Stock Analysis
When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.